PubMed HealthSearch

PubMed · 6950686

The major histocompatibility complex.

Abstract

The major histocompatibility complex on the sixth chromosome controls expression of a complex series of cell surface antigens which comprise the human leukocyte antigen (HLA) system. These markers, beyond their importance in human organ transplantation, have been demonstrated to occur with an increased prevalence in certain disease states. The group of conditions showing the closest association with specific HLA antigens are the "spondyloarthropathies." These include ankylosing spondylitis (AS), Reiter's syndrome (RS), psoriatic arthritis (PsA), and the arthritis of inflammatory bowel disease (AIBD). Clinical and radiographic studies were made of 310 unrelated caucasoid patients with seronegative arthritis. HLA-A, B, C, and DR typing were performed using the microdroplet lymphocyte cytotoxicity test. Statistically increased prevalences of A26, B27, and Bw38 were observed, while B27 was associated with spinal involvement regardless of diagnosis (90 percent in AS p less than 0.0001). Experiments found A26 (23 percent p less than 0.001) and Bw38 (38 percent p less than 0.0001) in patients with PsA. Spondyloarthritis patients with spinal involvement who lacked B27 frequently had B7. The HLA DR typing for seven specificities was carried out in 196 patients. It was found that DRw4 (52 percent p less than 0.03) and DRw7 (39 percent p less than 0.04) were increased in the PsA patients. This study further confirms the close association of HLA antigens and the spondylarthropathies.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F B Vasey, L R Espinoza, T S Bocanegra, B F Germain. The major histocompatibility complex.. https://pubmed.ncbi.nlm.nih.gov/6950686/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Radionuclide therapy.

Nuclear medicine therapy uses unsealed radioactive sources for the selective delivery of radiation to tumours or target organs. For benign disorders such as thyrotoxicosis and arthritis radionuclide therapy provides an alternative to surgery or medical treatment. In cancer treatment, it often combines the advantage of target selectivity (like brachytherapy or external beam radiotherapy) with that of being systemic, as with chemotherapy, and it may be used as part of a therapeutic strategy with curative intent or for disease control and palliation. Toxicity is generally limited to the haematopoietic tissue and few side-effects are observed. When cure is feasible, the long-term consequences of radionuclide therapy (eg, fertility disorders and leukaemia or other secondary cancers) do compare favourably with the risks associated with and accepted for chemotherapy and radiotherapy.

Arthritis

[Arthritis of the shoulder].

Diagnosis of shoulder arthritis should situate the precise location (glenohumeral, acromioclavicular, scapulothoracic) and rapidly determine the cause in order to eliminate the possibility of septic arthritis which requires urgent treatment. Good knowledge of shoulder symptomatology is essential. When there is joint effusion, the fluid should be sampled for rapid analysis (cells, crystals, germs), and the work-up for diagnosis must include clinical and laboratory analyses as well as imaging. Causes are especially microcrystallin arthritis (hydroxyapatite rheumatism, chondrocalcinosis, etc.) and inflammatory rheumatism (rheumatoid arthritis, ankylosis spondylitis, etc.). Septic arthritis is much less common but more rapidly destructive, which justifies their consideration whenever suspected. Treatment should be rapidly initiated in acute, particularly septic forms. In other forms, diagnosis guides treatment. Steps should be taken rapidly, both medically and sometimes surgically, to avoid destructive articular and periarticular lesions (rotator cuff).

Arthritis